Filing an orphan drug designation application with
Post# of 30028
Posted On: 10/16/2014 10:28:50 AM
Filing an orphan drug designation application with the FDA for MANF in Retinitis Pigmentosa and immediately thereafter will be submitting a second ocular orphan drug application for MANF with the FDA - See more at:
http://www.thechairmansblog.com/amarantus-bio...Lafz3.dpuf
http://www.thechairmansblog.com/amarantus-bio...Lafz3.dpuf
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼